Effects of Efavirenz Binding on the Subunit Equilibria of HIV-1 Reverse Transcriptase
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Recent studies showed that nonnucleoside reverse transcriptase inhibitors (NNRTIs) have variable effects on dimerization of p66 and p51 subunits of HIV-1 reverse transcriptase (RT). Efavirenz, one of three NNRTIs currently used in highly active anti-retroviral therapy, enhances subunit dimerization. Sedimentation equilibrium experiments on each subunit and equimolar mixtures of both subunits were used to measure dissociation constants for the three coupled dimerization reactions of RT in the absence and presence of saturating concentrations of the drug. The dimerization constants of the p51/p51 homodimer, the p66/p66 homodimer, and the p66/p51 heterodimer increased 600-, 50-, and 25-fold, respectively, upon binding of efavirenz. The effects of NNRTIs on RT dimerization are consistent with a thermodynamic linkage between subunit association/dissociation and inhibitor binding. Analysis of crystal structures of the p66/p51 heterodimer reveals that efavirenz binding induces small structural changes at the dimer interface.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nevertheless, this approach is supported by the observation that a single substitution mutation in RT significantly lowers the dimerization affinity, suggesting that it is possible to reduce dimerization by targeting key contacts in the interface [107,118-121].”
From Retroviral RNase H: structure, mechanism, and inhibition (2021) · cites this paper as [119]
Citations
Cites
Press, W. H., Flannery, B. P., Teukolsky, S. A., & Vetterling, W. T. (2007) · Cited by 796
Rapid Attainment of Sedimentation Equilibrium
Van Holde, K. E., & Baldwin, R. L. (1958) · The Journal of Physical Chemistry · doi:10.1021/j150564a025 · Cited by 763
Restle, T., Müller, B., & Goody, R. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38799-x · Cited by 184
Lindberg, J., Sigurðsson, S., Löwgren, S., Andersson, H. O., Sahlberg, C., Noréen, R., Fridborg, K., Zhang, H., & Unge, T. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2002.02811.x · Cited by 136
RNase H activity of HIV reverse transcriptases is confined exclusively to the dimeric forms
Restle, T., Müller, B., & Goody, R. S. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80172-d · Cited by 68
Kensch, O., Restle, T., Wöhrl, B. M., Goody, R. S., & Steinhoff, H. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3998 · Cited by 59
Tachedjian, G., Moore, K. L., Goff, S. P., & Sluis‐Cremer, N. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.11.099 · Cited by 57
Peletskaya, E. N., Kogon, A. A., Tuske, S. J., Arnold, E., & Hughes, S. H. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3387-3397.2004 · Cited by 42
Bavand, M. R., Wagner, R., & Richmond, T. J. (1993) · Biochemistry · doi:10.1021/bi00091a003 · Cited by 30
Factors affecting the dimerization of the p66 form of HIV‐1 reverse transcriptase
Cabodevilla, J. F., Odriozola, L., Santiago, E., & Martínez-Irujo, J. J. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01939.x · Cited by 26
Research works printed but not linked: 31
- Le Grice S. F. J., 1991, EMBO J., 10
- Becerra S. P., 1991, Biochemistry 30, 11707−11719.
- Divita G., 1995, Biochemistry 34, 16337−16346.
- Lebowitz J., 1994, Protein Sci. 3, 1374−1382.
- Sluis-Cremer N., 2002, Mol. Pharmacol. 62, 398−405.
- Sluis-Cremer N., 2000, Biochemistry 39, 1427−1433.
- Mao C., 2000, Biochem. Pharmacol. 60, 1251−1265.
- Sluis-Cremer N., 2004, Curr. HIV Res. 2, 323−332.
- Borkow G., 1997, Biochemistry 36, 3179−3185.
- Tachedjian G., 2001, Proc. Natl. Acad. Sci. U.S.A. 98
- Merluzzi V. J., 1990, Science 250, 1411−1413.
- Spence R. A., 1995, Science 267, 988−993.
- Kohlstaedt L. A., 1992, Science 256, 1783−1790.
- Ren J., 2000, Structure 8, 1089−1094.
- Le Grice S. F. J., 1995, Methods Enzymol. 262, 130−144.
- Gill S. C., 1989, Anal. Biochem. 182, 319−326.
- Ignatov M. E., 2005, Biochemistry 44, 5346−5356.
- Makhatadze G. I., 1990, Partial molar, 30
- Gekko K., 1981, Biochemistry 20, 4667−4676.
- Osbourne J. C., Jr., 1984, J. Biol. Chem., 259
- Lewis M. S., 2004, Methods Enzymol. 384, 232−242.
- Rodgers D. W., 1995, Proc. Natl. Acad. Sci. U.S.A. 92
- Hsiou Y., 1996, Structure 4, 853−857.
- Holladay L. A., 1972, J. Biol. Chem., 247
- Rausch J. W., 2000, J. Biol. Chem., 275
- Rothwell P. J., 2003, Proc. Natl. Acad. Sci. U.S.A. 100, 1655−1660.
- Young S. D., 1995, Antimicrob. Agents Chemother. 39, 2602−2605.
- Maga G., 2000, Antimicrob. Agents Chemother. 44, 1186−1194.
- Tachedjian G., 2005, Bioinf., 60, 13
- Wang J., 1994, Proc. Natl. Acad. Sci. U.S.A. 91
- Jacobo-Molina A., 1993, Proc. Natl. Acad. Sci. U.S.A. 90
Cited by
Dynamic binding orientations direct activity of HIV reverse transcriptase
Abbondanzieri, E. A., Bokinsky, G., Rausch, J. W., Zhang, J. X., Le Grice, S. F. J., & Zhuang, X. (2008) · Nature · doi:10.1038/nature06941 · Cited by 186
Mechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitors
Sluis-Cremer, N., & Tachedjian, G. (2008) · Virus Research · doi:10.1016/j.virusres.2008.01.002 · Cited by 172
Potent Nonnucleoside Reverse Transcriptase Inhibitors Target HIV-1 Gag-Pol
Figueiredo, A., Moore, K. L., Mak, J., Sluis‐Cremer, N., de Béthune, M., & Tachedjian, G. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020119 · Cited by 118
Liu, S., Harada, B. T., Miller, J. T., Grice, S. F. J. L., & Zhuang, X. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1937 · Cited by 75
Allosteric Suppression of HIV-1 Reverse Transcriptase Structural Dynamics upon Inhibitor Binding
Seckler, J. M., Barkley, M. D., & Wintrode, P. L. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2010.11.004 · Cited by 57
Self-citationMenéndez‐Arias, L., Betancor, G., & Matamoros, T. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.08.020 · Cited by 51
Geitmann, M., Unge, T., & Danielson, U. H. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0504050 · Cited by 51
Kinase Substrate Sensor (KISS), a Mammalian In Situ Protein Interaction Sensor
Lievens, S., Gerlo, S., Lemmens, I. H., Clercq, D. J. H. D., Risseeuw, M., Vanderroost, N., de Smet, A.-S., Ruyssinck, E., Chevet, É., Calenbergh, S. V., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.041087 · Cited by 47
Efavirenz Binding to HIV-1 Reverse Transcriptase Monomers and Dimers
Braz, V. A., Holladay, L. A., & Barkley, M. D. (2009) · Biochemistry · doi:10.1021/bi901579y · Cited by 40
Self-citationSolution Structural Dynamics of HIV-1 Reverse Transcriptase Heterodimer
Seckler, J. M., Howard, K. J., Barkley, M. D., & Wintrode, P. L. (2009) · Biochemistry · doi:10.1021/bi900790x · Cited by 37
Self-citationJochmans, D., Anders‐Össwein, M., Keuleers, I., Smeulders, L., Kräusslich, H., Kraus, G., & Müller, B. (2010) · Retrovirology · doi:10.1186/1742-4690-7-89 · Cited by 37
Sharaf, N. G., Ishima, R., & Gronenborn, A. M. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00113 · Cited by 37
Geitmann, M., Unge, T., & Danielson, U. H. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0504048 · Cited by 37
Marko, R., Liu, H.-W., Ablenas, C. J., Ehteshami, M., Götte, M., & Cosa, G. (2013) · The Journal of Physical Chemistry B · doi:10.1021/jp308674g · Cited by 35
Agopian, A., Gros, E., Aldrian, G., Dereuddre‐Bosquet, N., Clayette, P., & Divita, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802199200 · Cited by 33
Zheng, X., Pedersen, L. C., Gabel, S. A., Mueller, G. A., Cuneo, M. J., DeRose, E. F., Krahn, J. M., & London, R. E. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku143 · Cited by 31
Kinetics of Association and Dissociation of HIV-1 Reverse Transcriptase Subunits
Venezia, C. F., Meany, B. J., Braz, V. A., & Barkley, M. D. (2009) · Biochemistry · doi:10.1021/bi9010495 · Cited by 29
Self-citationThe use of analytical sedimentation velocity to extract thermodynamic linkage
Cole, J. L., Correia, J. J., & Stafford, W. F. (2011) · Biophysical Chemistry · doi:10.1016/j.bpc.2011.05.014 · Cited by 26
The p66 immature precursor of HIV-1 reverse transcriptase
Sharaf, N. G., Poliner, E., Slack, R. L., Christen, M. T., Byeon, I. L., Parniak, M. A., Gronenborn, A. M., & Ishima, R. (2014) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24594 · Cited by 25
Separation of protein oligomers by blue native gel electrophoresis
Braz, V. A., & Howard, K. J. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.02.019 · Cited by 24
Self-citationParedes, R., Puertas, M. C., Bannister, W. P., Kisic, M., Cozzi‐Lepri, A., Pou, C., Bellido, R., Betancor, G., Bogner, J. R., Gargalianos, P., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir385 · Cited by 23
Solution characterization of [methyl-13C]methionine HIV-1 reverse transcriptase by NMR spectroscopy
Zheng, X., Mueller, G. A., DeRose, E. F., & London, R. E. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.07.021 · Cited by 23
Homodimerization of the p51 Subunit of HIV-1 Reverse Transcriptase
Zheng, X., Mueller, G. A., Cuneo, M. J., DeRose, E. F., & London, R. E. (2010) · Biochemistry · doi:10.1021/bi902116z · Cited by 23
Efavirenz Enhances HIV-1 Gag Processing at the Plasma Membrane through Gag-Pol Dimerization
Sudo, S., Haraguchi, H., Hirai, Y., Gatanaga, H., Sakuragi, J.-I., Momose, F., & Morikawa, Y. (2013) · Journal of Virology · doi:10.1128/jvi.02306-12 · Cited by 22
Chiang, C.-C., Wang, S.-M., Tseng, Y.-T., Huang, K.-J., & Wang, C.-T. (2008) · Virology · doi:10.1016/j.virol.2008.10.027 · Cited by 22
Efavirenz Binding Site in HIV-1 Reverse Transcriptase Monomers
Braz, V. A., Barkley, M. D., Jockusch, R. A., & Wintrode, P. L. (2010) · Biochemistry · doi:10.1021/bi101480z · Cited by 21
Self-citationThe Triple Threat of HIV-1 Protease Inhibitors
Potempa, M., Lee, S.-K., Wolfenden, R. V., & Swanstrom, R. I. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_438 · Cited by 20
Asymmetric conformational maturation of HIV-1 reverse transcriptase
Zheng, X., Perera, L., Mueller, G. A., DeRose, E. F., & London, R. E. (2015) · eLife · doi:10.7554/elife.06359 · Cited by 19
A Single Amino Acid Substitution in HIV-1 Reverse Transcriptase Significantly Reduces Virion Release
Chiang, C.-C., Wang, S.-M., Pan, Y.-Y., Huang, K.-J., & Wang, C.-T. (2009) · Journal of Virology · doi:10.1128/jvi.01532-09 · Cited by 19
Pan, Y.-Y., Wang, S.-M., Huang, K.-J., Chiang, C.-C., & Wang, C.-T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032845 · Cited by 18
Structural Maturation of HIV-1 Reverse Transcriptase—A Metamorphic Solution to Genomic Instability
London, R. E. (2016) · Viruses · doi:10.3390/v8100260 · Cited by 16
Pattyn, E., Lavens, D., der Heyden, J. V., Verhee, A., Lievens, S., Lemmens, I. H., Hallenberger, S., Jochmans, D., & Tavernier, J. H. (2008) · Journal of Virological Methods · doi:10.1016/j.jviromet.2008.06.021 · Cited by 16
Single-molecule fluorescence imaging: Generating insights into molecular interactions in virology
Banerjee, S., Maurya, S., & Roy, R. (2018) · Journal of Biosciences · doi:10.1007/s12038-018-9769-y · Cited by 15
Schauer, G. D., Leuba, S. H., & Sluis‐Cremer, N. (2013) · Biomolecules · doi:10.3390/biom3040889 · Cited by 14
Retroviral RNase H: structure, mechanism, and inhibition
(2021) · The Enzymes · doi:10.1016/bs.enz.2021.07.007 · Cited by 13
Boonsri, P., Kuno, M., & Hannongbua, S. (2011) · MedChemComm · doi:10.1039/c1md00162k · Cited by 13
Sharaf, N. G., Xi, Z., Ishima, R., & Gronenborn, A. M. (2017) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25383 · Cited by 13
Chiang, C.-C., Tseng, Y.-T., Huang, K.-J., Pan, Y.-Y., & Wang, C.-T. (2011) · Virology · doi:10.1016/j.virol.2011.11.001 · Cited by 12
Targeting Human Immunodeficiency Virus Type 1 Assembly, Maturation and Budding
Wapling, J., Srivastava, S., Shehu-Xhilaga, M., & Tachedjian, G. (2007) · Drug Target Insights · doi:10.1177/117739280700200020 · Cited by 12
Hsieh, S.-H., Yu, F.-H., Huang, K.-J., & Wang, C.-T. (2023) · Journal of Virology · doi:10.1128/jvi.00948-23 · Cited by 9
Effect of tRNA on the Maturation of HIV-1 Reverse Transcriptase
Ilina, T. V., Slack, R. L., Elder, J. H., Sarafianos, S. G., Parniak, M. A., & Ishima, R. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.02.027 · Cited by 9
Zhang, H., Wang, Y., Wu, H., Jin, D., Wen, Y., & Zheng, B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006108 · Cited by 8
Conformational Changes in HIV-1 Reverse Transcriptase that Facilitate Its Maturation
Slack, R. L., Ilina, T. V., Xi, Z., Giacobbi, N. S., Kawai, G., Parniak, M. A., Sarafianos, S. G., Cremer, N. S., & Ishima, R. (2019) · Structure · doi:10.1016/j.str.2019.08.004 · Cited by 8
Identification of drivers for the metamorphic transition of HIV-1 reverse transcriptase
Zheng, X., Mueller, G. A., Kim, K., Perera, L., DeRose, E. F., & London, R. E. (2017) · Biochemical Journal · doi:10.1042/bcj20170480 · Cited by 7
Goswami, D., Tuske, S., Pascal, B. D., Bauman, J. D., Patel, D., Arnold, E., & Griffin, P. R. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b00372 · Cited by 7
Hollander, K., Devarkar, S. C., Tang, S., Tiwari, R., Ma, S., Lee, W., Denn, E., Wang, Q., Spasov, K. A., Robbins, J. A., et al. (2025) · npj Drug Discovery. · doi:10.1038/s44386-025-00025-2 · Cited by 5
NMR structure of the HIV-1 reverse transcriptase thumb subdomain
Sharaf, N. G., Brereton, A. E., Byeon, I. L., Karplus, P. A., & Gronenborn, A. M. (2016) · Journal of Biomolecular NMR · doi:10.1007/s10858-016-0077-2 · Cited by 5
Interplay between protease and reverse transcriptase dimerization in a model HIV‐1 polyprotein
Chagas, B. C. A., Zhou, X., Guerrero, M., Ilina, T. V., & Ishima, R. (2024) · Protein Science · doi:10.1002/pro.5080 · Cited by 3
Effect of Lysyl–tRNA Synthetase on the Maturation of HIV-1 Reverse Transcriptase
Ilina, T. V., Slack, R. L., Guerrero, M., & Ishima, R. (2020) · ACS Omega · doi:10.1021/acsomega.0c01449 · Cited by 3
Press, B., Sapre, N. S., Pancholi, N., & Gupta, S. (2008) · Cited by 2
Large Multidomain Protein NMR: HIV-1 Reverse Transcriptase Precursor in Solution
Ilina, T. V., Xi, Z., Brosenitsch, T. A., Sluis‐Cremer, N., & Ishima, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249545 · Cited by 2
Braz, V. A. (2009) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 2
Hsieh, S.-H., Huang, K.-J., & Wang, C.-T. (2025) · Journal of Virology · doi:10.1128/jvi.02236-24 · Cited by 1
Pandey, A. K., Dixit, U., Kholodovych, V. V., Comollo, T. W., & Pandey, V. N. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00005 · Cited by 1
Relative domain orientation of the L289K HIV ‐1 reverse transcriptase monomer
Xi, Z., Ilina, T. V., Guerrero, M., Fan, L., Sluis‐Cremer, N., Wang, Y., & Ishima, R. (2022) · Protein Science · doi:10.1002/pro.4307 · Cited by 1
Šunjić, V., & Parnham, M. J. (2011) · Springer eBooks · doi:10.1007/978-3-0348-0125-6_13 · Cited by 1
Solution NMR studies of HIV-1 reverse transcriptase
Sharaf, N. G. (2017) · D-Scholarship@Pitt (University of Pittsburgh)
Targeting Small Molecules and Peptides to the p66-p51 Reverse Transcriptase Interface
Moussa, D. A., Agopian, A., & Divita, G. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7291-9_8
Effektivität von antiviralen Substanzen auf virale Infektionen
Langsch, P. (2023) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-33059
The Structural Dynamics of Human Immunodeficiency Virus Type I Reverse Transcriptase
Seckler, J. M. (2011) · OhioLink ETD Center (Ohio Library and Information Network)
Metadata
- Authors
- Venezia, C. F., Howard, K. J., Ignatov, M. E., Holladay, L. A., & Barkley, M. D.
- Affiliations
- Case Western Reserve University (US)
- Corresponding author
- Holladay, Leslie A.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2006-02-10
- Volume
- 45
- Issue
- 9
- Pages
- 2779-2789
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2085882047
- Cited by
- 59
- References
- 12
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 4 · 2016: 3 · 2015: 3 · 2014: 3 · 2013: 4 · 2012: 1
- FWCI
- 3.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01gm052263-08)
- National Heart, Lung, and Blood Institute (HL07653, T32HL007653)
- National Institute of General Medical Sciences (GM 52263)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- efavirenz, HIV-1 reverse transcriptase, non-nucleoside reverse transcriptase inhibitors, p66/p51 heterodimer, subunit dimerization, inhibitor binding, dissociation constant, antiretroviral therapy
- MeSH terms
- Alkynes, Binding Sites, Cyclopropanes, Kinetics, Oxazines, Protein Conformation, Structure-Activity Relationship, Thermodynamics, Reverse Transcriptase Inhibitors, Dimerization, Protein Subunits, Benzoxazines, HIV Reverse Transcriptase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.